IL-1R-associated kinase-1 mediates protein kinase Cδ-induced IL-1β production in monocytes

Journal of Immunology

Volumn 187, Issue 5, 2011, Pages 2632-2645

  Tiwari, Rajiv Lochan ^a   Singh, Vishal ^a   Singh, Ankita ^a   Barthwal, Manoj Kumar ^a  

^a CENTRAL DRUG RESEARCH INSTITUTE   (India)

Author keywords

[No Author keywords available]

Indexed keywords

CD11B ANTIGEN; CD36 ANTIGEN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1 RECEPTOR ASSOCIATED KINASE 1; INTERLEUKIN 1 RECEPTOR ASSOCIATED KINASE 3; INTERLEUKIN 1 RECEPTOR ASSOCIATED KINASE 4; INTERLEUKIN 1BETA; PHORBOL 12 ACETATE 13 MYRISTATE; PROTEIN KINASE C DELTA; PROTEIN KINASE INHIBITOR; ROTTLERIN; SMALL INTERFERING RNA; SN 50; STRESS ACTIVATED PROTEIN KINASE; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4; TRANSCRIPTION FACTOR AP 1;

ARTICLE; CELL LINE; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME REGULATION; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; MONOCYTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INTERACTION; RNA INTERFERENCE; WILD TYPE;

BLOTTING, WESTERN; CELL SEPARATION; ENZYME-LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; HUMANS; IMMUNOPRECIPITATION; INTERLEUKIN-1 RECEPTOR-ASSOCIATED KINASES; INTERLEUKIN-1BETA; MONOCYTES; PROTEIN KINASE C-DELTA; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION; TRANSFECTION;

EID: 80052678085     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1002526     Document Type: Article

References (58)

1. Maedler, K., G. Dharmadhikari, D. M. Schumann, and J. Størling. 2009. Interleukin-1β targeted therapy for type 2 diabetes. Expert Opin. Biol. Ther. 9: 1177-1188.
2. Schroder, K., R. Zhou, and J. Tschopp. 2010. The NLRP3 inflammasome: a sensor for metabolic danger? Science 327: 296-300.
3. Schroder, K., and J. Tschopp. 2010. The inflammasomes. Cell 140: 821-832.
4. Tiwari, R. L., V. Singh, and M. K. Barthwal. 2008. Macrophages: an elusive yet emerging therapeutic target of atherosclerosis. Med. Res. Rev. 28: 483-544. (Pubitemid 351842141)
5. Owyang, A. M., K. Maedler, L. Gross, J. Yin, L. Esposito, L. Shu, J. Jadhav, E. Domsgen, J. Bergemann, S. Lee, and S. Kantak. 2010. XOMA 052, an anti-IL-1β monoclonal antibody, improves glucose control and β-cell function in the diet-induced obesity mouse model. Endocrinology 151: 2515-2527.
6. Thomas, J. A., J. L. Allen, M. Tsen, T. Dubnicoff, J. Danao, X. C. Liao, Z. Cao, and S. A. Wasserman. 1999. Impaired cytokine signaling in mice lacking the IL-1 receptor-associated kinase. J. Immunol. 163: 978-984. (Pubitemid 29328110)
7. Kobayashi, K., L. D. Hernandez, J. E. Galán, C. A. Janeway, Jr., R. Medzhitov, and R. A. Flavell. 2002. IRAK-M is a negative regulator of Toll-like receptor signaling. Cell 110: 191-202. (Pubitemid 34876547)
8. Suzuki, N., S. Suzuki, G. S. Duncan, D. G. Millar, T. Wada, C. Mirtsos, H. Takada, A. Wakeham, A. Itie, S. Li, et al. 2002. Severe impairment of interleukin-1 and Toll-like receptor signalling in mice lacking IRAK-4. Nature 416: 750-756.
9. Janssens, S., and R. Beyaert. 2003. Functional diversity and regulation of different interleukin-1 receptor-associated kinase (IRAK) family members. Mol. Cell 11: 293-302. (Pubitemid 36293825)
10. Ghosh, S., and M. Karin. 2002. Missing pieces in the NF-κB puzzle. Cell 109 (Suppl.): S81-S96.
11. Kyriakis, J. M., and J. Avruch. 2001. Mammalian mitogen-activated protein kinase signal transduction pathways activated by stress and inflammation. Physiol. Rev. 81: 807-869. (Pubitemid 32267078)
12. Li, X., M. Commane, Z. Jiang, and G. R. Stark. 2001. IL-1-induced NFκB and c-Jun N-terminal kinase (JNK) activation diverge at IL-1 receptor-associated kinase (IRAK). Proc. Natl. Acad. Sci. USA 98: 4461-4465. (Pubitemid 32294999)
13. Li, S., A. Strelow, E. J. Fontana, and H. Wesche. 2002. IRAK-4: a novel member of the IRAK family with the properties of an IRAK-kinase. Proc. Natl. Acad. Sci. USA 99: 5567-5572. (Pubitemid 34411589)
14. Meylan, E., and J. Tschopp. 2008. IRAK2 takes its place in TLR signaling. Nat. Immunol. 9: 581-582. (Pubitemid 351712625)
15. Lin, S. C., Y. C. Lo, and H. Wu. 2010. Helical assembly in the MyD88-IRAK4-IRAK2 complex in TLR/IL-1R signalling. Nature 465: 885-890.
16. Adachi, O., T. Kawai, K. Takeda, M. Matsumoto, H. Tsutsui, M. Sakagami, K. Nakanishi, and S. Akira. 1998. Targeted disruption of the MyD88 gene results in loss of IL-1- and IL-18-mediated function. Immunity 9: 143-150. (Pubitemid 28361303)
17. Kawagoe, T., S. Sato, K. Matsushita, H. Kato, K. Matsui, Y. Kumagai, T. Saitoh, T. Kawai, O. Takeuchi, and S. Akira. 2008. Sequential control of Toll-like receptor-dependent responses by IRAK1 and IRAK2. Nat. Immunol. 9: 684-691. (Pubitemid 351712639)
18. Mamidipudi, V., C. Lin, M. L. Seibenhener, and M. W. Wooten. 2004. Regulation of interleukin receptor-associated kinase (IRAK) phosphorylation and signaling by iota protein kinase C. J. Biol. Chem. 279: 4161-4165. (Pubitemid 38199001)
19. Cuschieri, J., K. Umanskiy, and J. Solomkin. 2004. PKC-ζ is essential for endotoxin-induced macrophage activation. J. Surg. Res. 121: 76-83. (Pubitemid 39094099)
20. Kontny, E., M. Kurowska, K. Szczepańska, and W. Maśliński. 2000. Rottlerin, a PKC isozyme-selective inhibitor, affects signaling events and cytokine production in human monocytes. J. Leukoc. Biol. 67: 249-258.
21. Repnik, U., M. Knezevic, and M. Jeras. 2003. Simple and cost-effective isolation of monocytes from buffy coats. J. Immunol. Methods 278: 283-292. (Pubitemid 37281210)
22. Daigneault, M., J. A. Preston, H. M. Marriott, M. K. Whyte, and D. H. Dockrell. 2010. The identification of markers of macrophage differentiation in PMA-stimulated THP-1 cells and monocyte-derived macrophages. PLoS ONE 5: e8668.
23. Rovera, G., D. Santoli, and C. Damsky. 1979. Human promyelocytic leukemia cells in culture differentiate into macrophage-like cells when treated with a phorbol diester. Proc. Natl. Acad. Sci. USA 76: 2779-2783. (Pubitemid 9213164)
24. Barthwal, M. K., P. Sathyanarayana, C. N. Kundu, B. Rana, A. Pradeep, C. Sharma, J. R. Woodgett, and A. Rana. 2003. Negative regulation of mixed lineage kinase 3 by protein kinase B/AKT leads to cell survival. J. Biol. Chem. 278: 3897-3902. (Pubitemid 36801120)
25. Mishra, R., M. K. Barthwal, G. Sondarva, B. Rana, L. Wong, M. Chatterjee, J. R. Woodgett, and A. Rana. 2007. Glycogen synthase kinase-3b induces neuronal cell death via direct phosphorylation of mixed lineage kinase 3. J. Biol. Chem. 282: 30393-30405. (Pubitemid 350035219)
26. Armstrong, L., A. R. Medford, K. J. Hunter, K. M. Uppington, and A. B. Millar. 2004. Differential expression of Toll-like receptor (TLR)-2 and TLR-4 on monocytes in human sepsis. Clin. Exp. Immunol. 136: 312-319. (Pubitemid 38543451)
27. Brunialti, M. K., P. S. Martins, H. Barbosa de Carvalho, F. R. Machado, L. M. Barbosa, and R. Salomao. 2006. TLR2, TLR4, CD14, CD11B, and CD11C expressions on monocytes surface and cytokine production in patients with sepsis, severe sepsis, and septic shock. Shock 25: 351-357.
28. Garcia-Calvo, M., E. P. Peterson, B. Leiting, R. Ruel, D. W. Nicholson, and N. A. Thornberry. 1998. Inhibition of human caspases by peptide-based and macromolecular inhibitors. J. Biol. Chem. 273: 32608-32613. (Pubitemid 28557641)
29. Shanmugam, N., M. A. Reddy, M. Guha, and R. Natarajan. 2003. High glucose-induced expression of proinflammatory cytokine and chemokine genes in monocytic cells. Diabetes 52: 1256-1264. (Pubitemid 36523365)
30. Walker, R. J., and J. J. Steinle. 2007. Role of β-adrenergic receptors in inflammatory marker expression in Müller cells. Invest. Ophthalmol. Vis. Sci. 48: 5276-5281. (Pubitemid 351260941)
31. Wong, M. L., and J. F. Medrano. 2005. Real-time PCR for mRNA quantitation. Biotechniques 39: 75-85.
32. Yamin, T. T., and D. K. Miller. 1997. The interleukin-1 receptor-associated kinase is degraded by proteasomes following its phosphorylation. J. Biol. Chem. 272: 21540-21547.
33. Serkkola, E., and M. Hurme. 1993. Synergism between protein-kinase C and cAMP-dependent pathways in the expression of the interleukin-1β gene is mediated via the activator-protein-1 (AP-1) enhancer activity. Eur. J. Biochem. 213: 243-249. (Pubitemid 23106052)
34. Bensi, G., M. Mora, G. Raugei, D. T. Buonamassa, M. Rossini, and M. Melli. 1990. An inducible enhancer controls the expression of the human interleukin 1βgene. Cell Growth Differ. 1: 491-497.
35. Angel, P., M. Imagawa, R. Chiu, B. Stein, R. J. Imbra, H. J. Rahmsdorf, C. Jonat, P. Herrlich, and M. Karin. 1987. Phorbol ester-inducible genes contain a common cis element recognized by a TPA-modulated trans-acting factor. Cell 49: 729-739. (Pubitemid 18094763)
36. Clark, A. R., J. L. Dean, and J. Saklatvala. 2009. The p38 MAPK pathway mediates both antiinflammatory and proinflammatory processes: comment on the article by Damjanov and the editorial by Genovese. Arthritis Rheum. 60: 3513-3514.
37. Ibáñez, A., P. Río, J. A. Casado, J. A. Bueren, J. L. Fernández-Luna, and C. Pipaón. 2009. Elevated levels of IL-1β in Fanconi anaemia group A patients due to a constitutively active phosphoinositide 3-kinase-Akt pathway are capable of promoting tumour cell proliferation. Biochem. J. 422: 161-170.
38. Song, C., K. Hsu, E. Yamen, W. Yan, J. Fock, P. K. Witting, C. L. Geczy, and S. B. Freedman. 2009. Serum amyloid A induction of cytokines in monocytes/macrophages and lymphocytes. Atherosclerosis 207: 374-383.
39. Manjula, N., B. Gayathri, K. S. Vinaykumar, N. P. Shankernarayanan, R. A. Vishwakarma, and A. Balakrishnan. 2006. Inhibition of MAP kinases by crude extract and pure compound isolated from Commiphora mukul leads to down regulation of TNF-α, IL-1β and IL-2. Int. Immunopharmacol. 6: 122-132. (Pubitemid 43052809)
40. Genovese, M. C. 2009. Inhibition of p38: has the fat lady sung? Arthritis Rheum. 60: 317-320.
41. Schwende, H., E. Fitzke, P. Ambs, and P. Dieter. 1996. Differences in the state of differentiation of THP-1 cells induced by phorbol ester and 1,25-dihydroxyvitamin D3. J. Leukoc. Biol. 59: 555-561. (Pubitemid 26156616)
42. Zhou, L., L. H. Shen, L. H. Hu, H. Ge, J. Pu, D. J. Chai, Q. Shao, L. Wang, J. Z. Zeng, and B. He. 2010. Retinoid X receptor agonists inhibit phorbol-12-myristate-13-acetate (PMA)-induced differentiation of monocytic THP-1 cells into macrophages. Mol. Cell. Biochem. 335: 283-289.
43. Hutchings, P., H. Rosen, L. O'Reilly, E. Simpson, S. Gordon, and A. Cooke. 1990. Transfer of diabetes in mice prevented by blockade of adhesion-promoting receptor on macrophages. Nature 348: 639-642. (Pubitemid 120015126)
44. Weber, C., W. Erl, K. S. Weber, and P. C. Weber. 1997. HMG-CoA reductase inhibitors decrease CD11b expression and CD11b-dependent adhesion of monocytes to endothelium and reduce increased adhesiveness of monocytes isolated from patients with hypercholesterolemia. J. Am. Coll. Cardiol. 30: 1212-1217.
45. Hayden, J. M., L. Brachova, K. Higgins, L. Obermiller, A. Sevanian, S. Khandrika, and P. D. Reaven. 2002. Induction of monocyte differentiation and foam cell formation in vitro by 7-ketocholesterol. J. Lipid Res. 43: 26-35. (Pubitemid 34117214)
46. Edfeldt, K., J. Swedenborg, G. K. Hansson, and Z. Q. Yan. 2002. Expression of Toll-like receptors in human atherosclerotic lesions: a possible pathway for plaque activation. Circulation 105: 1158-1161. (Pubitemid 34225814)
47. Shibasaki, S., A. Imagawa, S. Tauriainen, M. Iino, M. Oikarinen, H. Abiru, K. Tamaki, H. Seino, K. Nishi, I. Takase, et al. 2010. Expression of Toll-like receptors in the pancreas of recent-onset fulminant type 1 diabetes. Endocr. J. 57: 211-219.
48. El Khoury, J. B., K. J. Moore, T. K. Means, J. Leung, K. Terada, M. Toft, M. W. Freeman, and A. D. Luster. 2003. CD36 mediates the innate host response to β-amyloid. J. Exp. Med. 197: 1657-1666. (Pubitemid 36745341)
49. Knop, J., and M. U. Martin. 1999. Effects of IL-1 receptor-associated kinase (IRAK) expression on IL-1 signaling are independent of its kinase activity. FEBS Lett. 448: 81-85. (Pubitemid 29151635)
50. Wang, Y., J. J. Zhang, W. Dai, K. Y. Lei, and J. W. Pike. 1997. Dexamethasone potently enhances phorbol ester-induced IL-1beta gene expression and nuclear factor NF-κB activation. J. Immunol. 159: 534-537. (Pubitemid 127484200)
51. Obenauer, J. C., L. C. Cantley, and M. B. Yaffe. 2003. Scansite 2.0: proteome-wide prediction of cell signaling interactions using short sequence motifs. Nucleic Acids Res. 31: 3635-3641. (Pubitemid 37442212)
52. Roux, P. P., S. A. Richards, and J. Blenis. 2003. Phosphorylation of p90 ribosomal S6 kinase (RSK) regulates extracellular signal-regulated kinase docking and RSK activity. Mol. Cell. Biol. 23: 4796-4804. (Pubitemid 36793327)
53. Chan, J. Y., A. Y. Chang, L. L. Wang, C. C. Ou, and S. H. Chan. 2007. Protein kinase C-dependent mitochondrial translocation of proapoptotic protein Bax on activation of inducible nitric-oxide synthase in rostral ventrolateral medulla mediates cardiovascular depression during experimental endotoxemia. Mol. Pharmacol. 71: 1129-1139. (Pubitemid 46457016)
54. Cruz, C. M., A. Rinna, H. J. Forman, A. L. Ventura, P. M. Persechini, and D. M. Ojcius. 2007. ATP activates a reactive oxygen species-dependent oxidative stress response and secretion of proinflammatory cytokines in macrophages. J. Biol. Chem. 282: 2871-2879. (Pubitemid 47084344)
55. Hu, Y., K. Mao, Y. Zeng, S. Chen, Z. Tao, C. Yang, S. Sun, X. Wu, G. Meng, and B. Sun. 2010. Tripartite-motif protein 30 negatively regulates NLRP3 inflammasome activation by modulating reactive oxygen species production. J. Immunol. 185: 7699-7705.
56. Bey, E. A., B. Xu, A. Bhattacharjee, C. M. Oldfield, X. Zhao, Q. Li, V. Subbulakshmi, G. M. Feldman, F. B. Wientjes, and M. K. Cathcart. 2004. Protein kinase Cδ is required for p47phox phosphorylation and translocation in activated human monocytes. J. Immunol. 173: 5730-5738. (Pubitemid 39392162)
57. Cole, J. E., E. Georgiou, and C. Monaco. 2010. The expression and functions of Toll-like receptors in atherosclerosis. Mediators Inflamm. 2010: 393946.
58. Feng, J., J. Han, S. F. Pearce, R. L. Silverstein, A. M. Gotto, Jr., D. P. Hajjar, and A. C. Nicholson. 2000. Induction of CD36 expression by oxidized LDL and IL-4 by a common signaling pathway dependent on protein kinase C and PPAR-γ. J. Lipid Res. 41: 688-696.